BeBetter Med Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Other Revenue	-	0.97	0.38	0.35
Revenue	-	0.97	0.38	0.35
Revenue Growth (YoY)	-	157.42%	7.55%	-
Cost of Revenue	-	0.57	0.18	0.11
Gross Profit	-	0.41	0.2	0.24
Selling, General & Admin	43.1	27.39	6.15	13.9
Research & Development	120.29	115.99	59.12	48.16
Other Operating Expenses	-98.34	0.06	0.02	-0.05
Operating Expenses	65.05	143.46	65.35	62.05
Operating Income	-65.05	-143.06	-65.14	-61.81
Interest Expense	-	-0.12	-	-
Interest & Investment Income	3.43	5.24	4.78	0.69
Currency Exchange Gain (Loss)	-	-0	-0.02	-
Other Non Operating Income (Expenses)	5.58	-6.34	-1.51	-0.01
EBT Excluding Unusual Items	-56.03	-144.28	-61.89	-61.13
Gain (Loss) on Sale of Investments	0.12	-	-	-0.02
Other Unusual Items	-	7.38	0.63	2.22
Pretax Income	-55.91	-136.9	-61.26	-58.94
Income Tax Expense	0.09	-	-	-
Net Income	-56	-136.9	-61.26	-58.94
Net Income to Common	-56	-136.9	-61.26	-58.94
Shares Outstanding (Basic)	350	360	-	-
Shares Outstanding (Diluted)	350	360	-	-
Shares Change (YoY)	-2.85%	-	-	-
EPS (Basic)	-0.16	-0.38	-	-
EPS (Diluted)	-0.16	-0.38	-	-
Free Cash Flow	-108.54	-106.76	-42.58	-5.86
Free Cash Flow Per Share	-0.31	-0.30	-	-
Gross Margin	-	41.76%	53.30%	68.70%
Operating Margin	-	-14743.80%	-17282.80%	-17636.55%
Profit Margin	-	-14109.31%	-16252.24%	-16815.97%
Free Cash Flow Margin	-	-11002.82%	-11295.58%	-1671.95%
EBITDA	-57.71	-142	-64.12	-60.87
D&A For EBITDA	7.34	1.06	1.03	0.94
EBIT	-65.05	-143.06	-65.14	-61.81
Revenue as Reported	-	0.97	0.38	0.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.